UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Acute Urinary Morbidity Following Stereotactic Body Radiation Therapy for Prostate Cancer with Prophylactic Alpha-Adrenergic Antagonist and Urethral Dose Reduction

Frontiers in oncology, 2016-05, Vol.6, p.122

2016

Volltextzugriff (PDF)

1054-P: A Physician Survey Focusing on Dose Escalation for Type 2 Diabetes Medications

Diabetes (New York, N.Y.), 2023-06, Vol.72 (Supplement_1), p.1

2023

Volltextzugriff (PDF)

Urethrogram-Directed Stereotactic Body Radiation Therapy for Clinically Localized Prostate Cancer in Patients with Contraindications to Magnetic Resonance Imaging

Frontiers in oncology, 2015-09, Vol.5, p.194-194

2015

Volltextzugriff (PDF)

Improved irritative voiding symptoms 3 years after stereotactic body radiation therapy for prostate cancer

Frontiers in oncology, 2014-10, Vol.4, p.290

2014

Volltextzugriff (PDF)

Stereotactic Body Radiation Therapy for Prostate Cancer: What is the Appropriate Patient-Reported Outcome for Clinical Trial Design?

Frontiers in oncology, 2015-03, Vol.5, p.77-77

2015

Volltextzugriff (PDF)

Proctitis 1 Week after Stereotactic Body Radiation Therapy for Prostate Cancer: Implications for Clinical Trial Design

Frontiers in oncology, 2016-07, Vol.6, p.167-167

2016

Volltextzugriff (PDF)

Intensity-Modulated Radiation Therapy with Stereotactic Body Radiation Therapy Boost for Unfavorable Prostate Cancer: The Georgetown University Experience

Frontiers in oncology, 2016-05, Vol.6, p.114-114

2016

Volltextzugriff (PDF)

Intensity-Modulated Radiation Therapy with Stereotactic Body Radiation Therapy Boost for Unfavorable Prostate Cancer: A Report on 3-Year Toxicity

Frontiers in oncology, 2017-02, Vol.7, p.5

2017

Volltextzugriff (PDF)

Improved irritative voiding symptoms three years after stereotactic body radiation therapy for prostate cancer

Frontiers in oncology, 2014-10, Vol.4

2014

Volltextzugriff (PDF)

What happened to anti-malarial markets after the Affordable Medicines Facility-malaria pilot? Trends in ACT availability, price and market share from five African countries under continuation of the private sector co-payment mechanism

Malaria journal, 2017-04, Vol.16 (1), p.173-173, Article 173

2017

Volltextzugriff (PDF)

Testing times: trends in availability, price, and market share of malaria diagnostics in the public and private healthcare sector across eight sub-Saharan African countries from 2009 to 2015

Malaria journal, 2017-05, Vol.16 (1), p.205-205, Article 205

2017

Volltextzugriff (PDF)

The malaria testing and treatment landscape in Kenya: results from a nationally representative survey among the public and private sector in 2016

Malaria journal, 2017-12, Vol.16 (1), p.494-13, Article 494

2017

Volltextzugriff (PDF)

Do anti-malarials in Africa meet quality standards? The market penetration of non quality-assured artemisinin combination therapy in eight African countries

Malaria journal, 2017-05, Vol.16 (1), p.204-21, Article 204

2017

Volltextzugriff (PDF)

Private sector role, readiness and performance for malaria case management in Uganda, 2015

Malaria journal, 2017-05, Vol.16 (1), p.219-219, Article 219

2017

Volltextzugriff (PDF)

Private sector opportunities and threats to achieving malaria elimination in the Greater Mekong Subregion: results from malaria outlet surveys in Cambodia, the Lao PDR, Myanmar, and Thailand

Malaria journal, 2017-05, Vol.16 (1), p.180-180, Article 180

2017

Volltextzugriff (PDF)

The malaria testing and treatment landscape in mainland Tanzania, 2016

Malaria journal, 2017-04, Vol.16 (1), p.202-202, Article 202

2017

Volltextzugriff (PDF)

When it just won't go away: oral artemisinin monotherapy in Nigeria, threatening lives, threatening progress

Malaria journal, 2017-12, Vol.16 (1), p.489-489, Article 489

2017

Volltextzugriff (PDF)

The malaria testing and treatment landscape in Benin

Malaria journal, 2017-04, Vol.16 (1), p.174-174, Article 174

2017

Volltextzugriff (PDF)

Insights into the availability and distribution of oral artemisinin monotherapy in Myanmar: evidence from a nationally representative outlet survey

Malaria journal, 2017-04, Vol.16 (1), p.170-170, Article 170

2017

Volltextzugriff (PDF)

Evidence on anti-malarial and diagnostic markets in Cambodia to guide malaria elimination strategies and policies

Malaria journal, 2017-04, Vol.16 (1), p.171-171, Article 171

2017

Volltextzugriff (PDF)

Anti-malarial landscape in Myanmar: results from a nationally representative survey among community health workers and the private sector outlets in 2015/2016

Malaria journal, 2017-04, Vol.16 (1), p.129-129, Article 129

2017

Volltextzugriff (PDF)

PROCTITIS ONE WEEK AFTER STEREOTACTIC BODY RADIATION THERAPY FOR PROSTATE CANCER: IMPLICATIONS FOR CLINICAL TRIAL DESIGN

Frontiers in oncology, 2016-07, Vol.6

2016

Volltextzugriff (PDF)

Effectiveness of Pelvic Floor Muscle and Education-Based Therapies on Bladder, Bowel, Vaginal, Sexual, Psychological Function, Quality of Life, and Pelvic Floor Muscle Function in Females Treated for Gynecological Cancer: A Systematic Review

Current oncology reports, 2024-08

2024

Volltextzugriff (PDF)

Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial

JAMA : the journal of the American Medical Association, 2011-04, Vol.305 (13), p.1305

2011

Volltextzugriff (PDF)

Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women

JAMA : the journal of the American Medical Association, 2010-10, Vol.304 (15), p.1684

2010

Volltextzugriff (PDF)

1 – 25 von 35

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(35)

Sprache

Englisch
(35)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Acute Urinary Morbidity Following Stereotactic Body Radiation Therapy for Prostate Cancer with Prophylactic Alpha-Adrenergic Antagonist and Urethral Dose Reduction

1054-P: A Physician Survey Focusing on Dose Escalation for Type 2 Diabetes Medications

Urethrogram-Directed Stereotactic Body Radiation Therapy for Clinically Localized Prostate Cancer in Patients with Contraindications to Magnetic Resonance Imaging

Improved irritative voiding symptoms 3 years after stereotactic body radiation therapy for prostate cancer

Stereotactic Body Radiation Therapy for Prostate Cancer: What is the Appropriate Patient-Reported Outcome for Clinical Trial Design?

Proctitis 1 Week after Stereotactic Body Radiation Therapy for Prostate Cancer: Implications for Clinical Trial Design

Intensity-Modulated Radiation Therapy with Stereotactic Body Radiation Therapy Boost for Unfavorable Prostate Cancer: The Georgetown University Experience

Intensity-Modulated Radiation Therapy with Stereotactic Body Radiation Therapy Boost for Unfavorable Prostate Cancer: A Report on 3-Year Toxicity

Improved irritative voiding symptoms three years after stereotactic body radiation therapy for prostate cancer

What happened to anti-malarial markets after the Affordable Medicines Facility-malaria pilot? Trends in ACT availability, price and market share from five African countries under continuation of the private sector co-payment mechanism

Testing times: trends in availability, price, and market share of malaria diagnostics in the public and private healthcare sector across eight sub-Saharan African countries from 2009 to 2015

The malaria testing and treatment landscape in Kenya: results from a nationally representative survey among the public and private sector in 2016

Do anti-malarials in Africa meet quality standards? The market penetration of non quality-assured artemisinin combination therapy in eight African countries

Private sector role, readiness and performance for malaria case management in Uganda, 2015

Private sector opportunities and threats to achieving malaria elimination in the Greater Mekong Subregion: results from malaria outlet surveys in Cambodia, the Lao PDR, Myanmar, and Thailand

The malaria testing and treatment landscape in mainland Tanzania, 2016

When it just won't go away: oral artemisinin monotherapy in Nigeria, threatening lives, threatening progress

The malaria testing and treatment landscape in Benin

Insights into the availability and distribution of oral artemisinin monotherapy in Myanmar: evidence from a nationally representative outlet survey

Evidence on anti-malarial and diagnostic markets in Cambodia to guide malaria elimination strategies and policies

Anti-malarial landscape in Myanmar: results from a nationally representative survey among community health workers and the private sector outlets in 2015/2016

PROCTITIS ONE WEEK AFTER STEREOTACTIC BODY RADIATION THERAPY FOR PROSTATE CANCER: IMPLICATIONS FOR CLINICAL TRIAL DESIGN

Effectiveness of Pelvic Floor Muscle and Education-Based Therapies on Bladder, Bowel, Vaginal, Sexual, Psychological Function, Quality of Life, and Pelvic Floor Muscle Function in Females Treated for Gynecological Cancer: A Systematic Review

Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial

Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women

Suchergebnisse filtern